Vir Biotechnology, Inc. — Director's Dealing 2023

May 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2023-05-22

Reporting Person: SHARP PHILLIP A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-22	Common Stock	A	6027	$0.00	Acquired	121174	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-22	Stock Option (Right to Buy)	$25.74	A	12054	Acquired	2033-05-21	Common Stock (12054)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	44444	Indirect
Common Stock	44444	Indirect
Common Stock	44444	Indirect

Footnotes

F1: The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Sarah Brokaw, over which the reporting person's spouse is co-trustee.

F2: The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Helena Sharp, over which the reporting person's spouse is co-trustee.

F3: The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Christine Carey, over which the reporting person's spouse is co-trustee.